a:5:{s:8:"template";s:5073:" {{ keyword }}
{{ text }}
";s:4:"text";s:8251:"We are pleased to be able to provide near-term value to our stockholders while ensuring the long-term future of the Company. SciClone is a publicly-held corporation based in Foster City, California, and trades on the NASDAQ Global Select Market under the symbol SCLN. This communication is being made in respect of the proposed merger transaction involving the Company and the Buyer Consortium. SciClone Pharmaceuticals and a consortium consisting of entities affiliated with GL Capital Management GP Limited, Bank of China Group Investment Limited, CDH Investments, Ascendent Capital Partners and Boying announced they have entered into a definitive merger agreement under which the Buyer Consortium will acquire all the outstanding shares of SciClone for $11.18 per share in … Those risks include, without limitation (i) the risk that the proposed transaction may not be completed in a timely manner, or at all, which may adversely affect the Company's business and the price of its common stock, (ii) the risk that the Buyer Consortium may fail to obtain financing, and notwithstanding that receipt of financing is not a closing condition, that the closing may not occur if Buyer Consortium is unable to secure adequate financing, (iii) the failure to satisfy all of the closing conditions of the proposed transaction, including the adoption of the definitive agreement by the Company's stockholders, (iv) the occurrence of any event, change or other circumstance that could give rise to the termination of the definitive agreement, (v) the effect of the announcement or pendency of the proposed transaction on the Company's business, operating results, and relationships with customers, suppliers and others, (vi) risks that the proposed transaction may disrupt the Company's current plans and business operations, (vii) potential difficulties retaining employees as a result of the proposed transaction, (viii) risks related to the diverting of management's attention from the Company's ongoing business operations, and (ix) the outcome of any legal proceedings that may be instituted against the Company related to the definitive agreement or the proposed transaction. Boying Investments Limited is a wholly owned limited company of Mr. Weihang Zhu. The British Council China is seeking proposals from suppliers who can develop 2 years advertising strategy and provide media planning and buying services for British Council in China. About GL Capital. Data is sourced from 13D/13G, 13F, and N-Q filings. SciClone's proprietary lead product, ZADAXIN(®) (thymalfasin), is approved in over 30 countries and may be used for the treatment of hepatitis B (HBV), hepatitis C (HCV), and certain cancers, and as an immune system enhancer, according to the local regulatory approvals. • ", "On behalf of the Buyer Consortium, I would like to express my deep appreciation and admiration to the Board and the management of SciClone. SciClone Pharmaceuticals, Inc. (SciClone ) is a global specialty pharmaceutical company. SciClone Pharmaceuticals, Inc. is a revenue-generating, specialty pharmaceutical company with a substantial commercial business in China and a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities. However, such documents are not currently available. Terms & Conditions | Privacy Policy, ...when SciClone Pharmaceuticals Inc. agreed to be taken private by an investor syndicate led by, ...SciClone Pharmaceuticals Inc. (NASDAQ:SCLN) said it will be acquired by an investor syndicate led by, ...SciClone received an unsolicited bid from a consortium led by ABM Management Ltd. and. Copies of the documents filed with the SEC by the Company will be available free of charge on the Company's website at www.sciclone.com under the heading "SEC Filings" in the "Investors and Media" portion of the Company's website. • For additional information, please visit www.sciclone.com. Files Registration Statement on Form S-4 with Preliminary Proxy Statement/Prospectus in Connection with Proposed Business Combination with AerSale, Repair, maintenance and associated services related to personal computers, office equipment, telecommunications and audio-visual equipment, ISDEF 2021, Defense & HLS Expo, June 1-3, Tel-Aviv, Israel, ISDEF 2020, October 20-21, Bangkok, Thailand, China National Nuclear Corporation (CNNC), China State Shipbuilding Corporation (CSSC). Another way to prevent getting this page in the future is to use Privacy Pass. With its extensive network of business relationships and knowledge of China's domestic economy, CDH is an ideal partner for global companies to tap on China's growth potential. IT technical support service to British Council China's office and test venue in China. All forward-looking statements are based on information currently available to SciClone and SciClone assumes no obligation to update any such forward-looking statements. The transaction, which was unanimously approved by SciClone's Board, values the Company at approximately $605 million, on a fully diluted basis, and represents a premium of 11% over SciClone's closing stock price on June 7, 2017 and a premium of 16% over its ten-day volume-weighted average closing stock price. Investors and security holders may obtain free copies of the definitive proxy statement, any amendments or supplements thereto and other documents containing important information about the Company, once such documents are filed with the SEC, through the website maintained by the SEC at www.sec.gov. SciClone is a publicly-held corporation based in Foster City, California, and trades on the NASDAQ Global Select Market under the symbol SCLN. The definitive proxy statement will be mailed to the stockholders of the Company. Established in 2010, GL Capital is a Greater China healthcare-focused, value-driven investment management group. Stockholders of the Company may also obtain a free copy of the definitive proxy statement and any filings with the SEC that are incorporated by reference in the definitive proxy statement by contacting the Company's Investor Relations Department at (650) 358-1447. Since inception, CDH has invested in more than 180 companies, and has helped more than 50 companies successfully list on the stock exchanges in the U.S., Hong Kong and China. Established in 2002, CDH Investments ("CDH") is one of the largest alternative asset management institutions focused on China, with over US$17 billion in assets under management as of 31 December 2016. ...Business: Supply/Service Date completed: 2/24/11 Type: Venture financing Raised: $40 million Investors: DCM; Legend Capital; © 2020 BioCentury Inc. All Rights Reserved. Many of these companies are sector leaders, and, collectively, they play an important role in China's economy. Guangzhou Hangxin Aviation Technology Co. Ltd. For additional information, please visit www.sciclone.com. GL Capital | 19 followers on LinkedIn | GL Capital | 19 followers on LinkedIn | LinkedIn. To the extent that holdings of the Company's securities by the Company's directors and executive officers have changed since the amounts printed in the latest proxy statement or Form 10-K, such changes have been or will be reflected on Statements of Change in Ownership on Form 4 filed with the SEC. We want to express our deep appreciation to our customers, partners, collaborators and employees. CDH has more than 100 investment professionals working in offices in Hong Kong, Singapore, Beijing, Shanghai and Shenzhen. This communication does not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company or the solicitation of any vote or approval. Additional information about these directors and executive officers is available in the Company's proxy statement for its 2017 Annual Meeting of Stockholders, which was filed with the SEC on April 28, 2017, and in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2016, which was filed with the SEC on March 9, 2017. GL Capital in Moses Lake, WA. ";s:7:"keyword";s:19:"sciclone gl capital";s:5:"links";s:817:"Sodastream Drink Mix, E Learning Ontario Login, Elisha Meaning, Grand Theatre Kingston Seating, Lpn Jobs In St Thomas Usvi, Maroon 5 Let's Stay Together, 1972 Pittsburgh Steelers Roster, ";s:7:"expired";i:-1;}